Navitus Welcomes New Members to the Board of Directors

May 14, 2024

MADISON, Wis., May 14, 2024 – Navitus Health Solutions, LLC today announced two updates to its Board of Directors. 

Lisa Erickson will be joining the Board as a Board Member. Lisa is Medica’s President and Chief Executive Officer, having joined as their Chief Financial Officer in 2023. She is also a member of the Board of Directors of Medica Holding Company, which oversees its family of businesses, including Dean Health Plan.

Lisa has more than 30 years of experience in a wide range of industries. Prior to joining Medica, she served as a Senior Vice President at Optum, where she led pharmacy network contracting and relationships, network operations, and pricing and underwriting. She also served as CFO of OptumInsight, and in financial leadership roles at several other organizations, including Best Buy, General Mills, The Pillsbury Company and TCF Bank (now known as Huntington Bank). She currently serves as a member of the Board of Directors of the Animal Humane Society and was previously a member on the Board of Trustees at the Academy of Holy Angels. 

Joseph Swedish will also be joining the Board as a Board Member. Joseph is the former Chairman, President and CEO of Anthem, Inc., (now known as Elevance Health) a Fortune 22 company serving over 117 million individuals through its broad portfolio of health insurance and service subsidiaries. During his tenure, Anthem’s average share price nearly quadrupled, and operating revenue increased 39% to over $89 billion. Previous to that, he served as CEO for several major integrated health care delivery systems, including President and CEO of Trinity Health.

As a business executive, conservationist, and philanthropist, Joseph also serves on the Board of Directors for CDW, Mesoblast, Centrexion Therapeutics, Accelus and The Nature Conservancy (Colorado). Modern Healthcare named him one of the 100 Most Influential People in Healthcare for 12 years in a row.

“I am certain that the collaborative natures of Lisa and Joseph will be invaluable to our mission. Their collective industry and business expertise will not only contribute to strengthening our organization, but will further enable us to navigate the future with confidence and agility.”  – David Fields, President and CEO of Navitus Health Solutions

With these appointments, the Board of Directors consists of five Board Members, a Vice Chair and a Chair of the Board.

About Navitus

Navitus Health Solutions, LLC, owned by SSM Health and Costco Wholesale Corporation, was founded in 2003 as an alternative to traditional pharmacy benefit manager (PBM) models. Navitus approaches pharmacy services fundamentally differently. We are purpose-driven to help humans and committed to removing costs from the drug supply chain to make medications more affordable for the people who need them. As an enterprise, we proudly serve over 14 million members through nearly 800 client relationships. Our transparent, fully pass-through model enables our clients to achieve their goals and drive desired health and financial outcomes. To learn more about Navitus, visit www.navitus.com

For questions and media inquiries, contact [email protected].

MORE ABOUT DAVID Fields

David Fields is the President and CEO at Navitus Health Solutions. He provides enterprise leadership and strategic direction for Navitus, collaborating with the executive management team to maintain Navitus strategic plan and to develop and direct its goals, policies and execution. David has held leadership positions on a number of boards, including the American Heart Association, American Red Cross, Labor-Management Council and the National Conference of Christians and Jews.

MORE ABOUT Lisa erickson

Lisa Erickson, President and CEO of Medica and a member of Medica Holding Company’s Board of Directors, brings over 30 years of diverse industry experience, including leadership roles at Optum, Best Buy, General Mills, and TCF Bank, and holds business degrees from the University of Wisconsin-Madison and the University of Minnesota.

MORE ABOUT Josephi Swedish

Joseph R. Swedish, former Chairman, President, and CEO of Anthem, Inc. (now Elevance Health), is a distinguished healthcare leader and philanthropist with a legacy of transforming organizations through strategic growth, operational excellence, and innovative governance, and has held influential roles across health systems, private equity, and major corporate boards

Stay Informed and Connected

Receive expert insights, healthcare tips, and important updates on pharmacy benefits, drug recalls, and more—straight to your inbox.

Examining Trends that Drive Informed Decisions

Now Available: 8th Annual Drug Trend Report

See the latest results and access industry insights you need to navigate current trend drivers.

Related blogs

Navigating Healthcare and Improving Outcomes

Associate Resource Group Spotlight: Green Team

Associate Resource Group Spotlight: Green Team

The Green Team believes that small changes lead to significant impact. Whether its reducing waste, conserving energy or implementing eco-friendly initiatives, they serve as an internal hub for expertise regarding environmental sustainability….

PBM 101: The Three PBM Business Models

PBM 101: The Three PBM Business Models

In the pharmaceutical and healthcare industry, pharmacy benefit managers (PBMs) are regarded by the media as intermediaries between drug manufacturers, pharmacies, health plans and plan sponsors. But they’re so much more than that. PBMs act as conduits…

An Automated Approach to Diagnosis Verification of GLP-1 RA for Type 2 Diabetes Mellitus (T2DM)

An Automated Approach to Diagnosis Verification of GLP-1 RA for Type 2 Diabetes Mellitus (T2DM)

This study examines the impact of implementing an automated point-of-sale diagnosis verification system for glucagon-like peptide-1 receptor agonists (GLP-1 RAs) compared to traditional utilization management approaches….

Navitus to Remove Stelara® from Formulary July 1, 2025, Adds Biosimilars to Drive $120 Million in Savings 

Navitus to Remove Stelara® from Formulary July 1, 2025, Adds Biosimilars to Drive $120 Million in Savings 

As the nation’s first 100% transparent, pass-through PBM, we continue to advance medication affordability by prioritizing upfront, real-time savings over rebated models….

Achieving Outstanding Results with Tailored Network Strategies

Achieving Outstanding Results with Tailored Network Strategies

A medium-sized city in Michigan with 1,350 members was seeking ways to lower its pharmacy benefit costs, which were growing under its existing traditional pharmacy benefit manager (PBM). With its member covered by a two-tier, open formulary including…

Breaking Through Barriers with Value-Based Plan Design

Breaking Through Barriers with Value-Based Plan Design

Facing increased pharmacy benefit expenses, Blain’s Farm and Fleet, a Midwestern employer group, desired to improve plan performance. Specifically it was interested in educating eligible members about the benefits available to them, promoting cost-effective…

Finding a Solution to Lower Prescription Drug Costs

Finding a Solution to Lower Prescription Drug Costs

The Rural Arizona Group Health Trust (RAGHT) wanted to gain better control of its escalating drug trend with its large, traditional pharmacy benefit manager (PBM). Having only worked with traditional PBMs in the past, RAGHT was interested in exploring…

Empowered by Strategic Opportunities and Service Excellence

Empowered by Strategic Opportunities and Service Excellence

Putnam | Northern Westchester Health Benefits Consortium (PNW HBC) was the first municipal cooperative health plan in the state of New York to become certified by the Department of Insurance. They are dedicated to meeting — and exceeding — the standards…

QALYiQ Program Delivers Significant Savings for Both Members and Health Plans

QALYiQ Program Delivers Significant Savings for Both Members and Health Plans

As part of their treatment plan for hypophosphatasia (HPP), a rare genetic disorder affecting bone and teeth development, one of our members required Strensiq, a medication designed to manage HPP. However, Strensiq’s annual treatment costs ranged from…

previous arrow
next arrow